Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CD34+ stem cells in acute ischemic stroke
NCT00535197Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Sep 2007
- Primary completion
- Jul 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD34+ cells in ischemic stroke, sponsored by Imperial College London. Started Sep 2007; status: completed.
02
Drugs
autologous CD34+ cells
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00535197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535197.